Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Evin Gulbahce

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Pathology|October 3, 2017
Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference LaboratoryH Evin Gulbahce
Seminars in Diagnostic Pathology|November 7, 2024
"Lobular lesions of the breast: From the classic to the variants"Erinn Downs, H Evin Gulbahce
Neurosurgery|May 28, 2005
Ewing's sarcoma of the cavernous sinus: case reportMedina Kushen, H Evin Gulbahce, Cornelius H Lam
Cancer Genetics|July 30, 2025
Resolving HER2 status in breast carcinoma patients with complete deletion of CEP17 in fluorescence in-situ hybridization assaysDiane M Wilcock, Jian Zhao, H Evin Gulbahce
Human Pathology|October 26, 2013
Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancerH Evin Gulbahce, Steve Vanderwerf, Cindy Blair, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 19, 2021
RAI1 alternate probe identifies additional gastroesophageal adenocarcinoma cases as amplified following equivocal HER2 fluorescence in situ hybridization testing: experience from a national reference laboratoryJolanta Jedrzkiewicz, Deepika Sirohi, Nermin Uvejzovic, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 11, 2020
What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory ExperienceJonathon Mahlow, Eric A Goold, Jolanta Jedrzkiewicz, et al.
Pancreas|April 21, 2004
Intraductal papillary mucinous tumor of the native pancreas in a pancreas-kidney transplant recipientTun Jie, James V Harmon, H Evin Gulbahce, et al.
Cancer|June 30, 2007
Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda systemMichael Thrall, Klint Kjeldahl, H Evin Gulbahce, et al.
Diagnostic Cytopathology|June 29, 2011
Fine-needle aspiration diagnosis of metastatic intestinal-type sinonasal adenocarcinomaCharanjeet Singh, Jose Jessurun, H Evin Gulbahce, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|October 3, 2017
Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference LaboratoryH Evin Gulbahce
Seminars in Diagnostic Pathology|November 7, 2024
"Lobular lesions of the breast: From the classic to the variants"Erinn Downs, H Evin Gulbahce
Neurosurgery|May 28, 2005
Ewing's sarcoma of the cavernous sinus: case reportMedina Kushen, H Evin Gulbahce, Cornelius H Lam
Cancer Genetics|July 30, 2025
Resolving HER2 status in breast carcinoma patients with complete deletion of CEP17 in fluorescence in-situ hybridization assaysDiane M Wilcock, Jian Zhao, H Evin Gulbahce
Human Pathology|October 26, 2013
Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancerH Evin Gulbahce, Steve Vanderwerf, Cindy Blair, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 19, 2021
RAI1 alternate probe identifies additional gastroesophageal adenocarcinoma cases as amplified following equivocal HER2 fluorescence in situ hybridization testing: experience from a national reference laboratoryJolanta Jedrzkiewicz, Deepika Sirohi, Nermin Uvejzovic, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 11, 2020
What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory ExperienceJonathon Mahlow, Eric A Goold, Jolanta Jedrzkiewicz, et al.
Pancreas|April 21, 2004
Intraductal papillary mucinous tumor of the native pancreas in a pancreas-kidney transplant recipientTun Jie, James V Harmon, H Evin Gulbahce, et al.
Cancer|June 30, 2007
Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda systemMichael Thrall, Klint Kjeldahl, H Evin Gulbahce, et al.
Diagnostic Cytopathology|June 29, 2011
Fine-needle aspiration diagnosis of metastatic intestinal-type sinonasal adenocarcinomaCharanjeet Singh, Jose Jessurun, H Evin Gulbahce, et al.
Pageof 6